Aadi Bioscience, Inc. (AADI) can sell. Click on Rating Page for detail.
The price of Aadi Bioscience, Inc. (AADI) is 1.75 and it was updated on 2024-04-28 07:00:40.
Currently Aadi Bioscience, Inc. (AADI) is in undervalued.
News |
---|
Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue Estimates
|
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)
|
Why Is Aadi Bioscience (AADI) Stock Down 56% Today?
|
Aadi Bioscience, Inc. (AADI) Q3 2023 Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) Reports Q2 Loss, Tops Revenue Estimates
|
Transcipts Data |
---|
Aadi Bioscience, Inc. (AADI) on Q3 2023 Results - Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) on Q2 2023 Results - Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) on Q1 2023 Results - Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) on Q4 2022 Results - Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) on Q3 2022 Results - Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) on Q2 2022 Results - Earnings Call Transcript
|
Aadi Bioscience, Inc. (AADI) on Q1 2022 Results - Earnings Call Transcript
|
StockPrice Release |
---|
News |
---|
Aadi Bioscience: High Risk/High Reward
|
Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting
|
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023
|
Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Tops Revenue Estimates
|
Aadi Bioscience: Commercial Stage With Large Market In Label Expansion
|
Aadi Bioscience, Inc. (AADI) Upgraded to Buy: What Does It Mean for the Stock?
|
Aadi Bioscience, Inc. (AADI) Q3 2022 Earnings Call Transcript
|
Aadi Bioscience: Taking mTOR Inhibition To The Next Level
|
Aadi Bioscience, Inc. (AADI) CEO Neil Desai on Q2 2022 Results - Earnings Call Transcript
|
Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference
|
Aadi Bioscience, Inc. (AADI) CEO Neil Desai on Q1 2022 Results - Earnings Call Transcript
|
Aadi Bioscience to Announce First Quarter 2022 Financial Results on May 12, 2022
|
Aadi Bioscience to Present at 2022 H.C. Wainwright BioConnect Virtual Conference
|
Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
|
Aadi Bioscience (AADI) Stock: Why The Price Surged Today
|
Aadi Bioscience Shares Rally On FDA Approval For Its First Product For Rare Form Cancer
|
Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Misses Revenue Estimates
|
Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer
|